Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation

被引：0
|
作者：
Liuzzo, Giovanna [1 ,2 ]
Patrono, Carlo [3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Catholic Univ, Sch Med, Cardiovasc & Pulm Sci, Largo F Vito 1, I-00168 Rome, Italy
[3] Catholic Univ, Pharmacol, Sch Med, Largo F Vito 1, I-00168 Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 06期
关键词：
EFFICACY; REGISTRY; SAFETY;
D O I：
10.1093/eurheartj/ehac721
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [21] Factor Xa Inhibitors Versus Vitamin K Antagonists in Atrial Fibrillation Patients with End-Stage Kidney Disease on Dialysis: A Meta-Analysis
    Xiong, Meimei
    Guo, Linjuan
    Wan, Yun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [22] Safety and Effectiveness Outcomes between Apixaban Versus Vitamin K Antagonists in Atrial Fibrillation Patients on Dialysis
    Guo, Zongwen
    Wang, Yufan
    Ding, Xiaoli
    Lai, Jiying
    Chen, Yijian
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (09)
  • [23] Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
    Reers, Stefan
    Karanatsios, Georg
    Borowski, Matthias
    Kellner, Michael
    Reppel, Michael
    Waltenberger, Johannes
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2018, 23
  • [24] Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation The Use of Non-Vitamin K-Dependent Anticoagulants and Vitamin K Antagonists
    Heine, Gunnar H.
    Brandenburg, Vincent
    Schirmer, Stephan H.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (17): : 287 - +
  • [25] Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety Outcomes
    Parrini, Iris
    Luca, Fabiana
    Rao, Carmelo Massimiliano
    Parise, Gianmarco
    Micali, Linda Renata
    Musumeci, Giuseppe
    La Meir, Mark
    Colivicchi, Furio
    Gulizia, Michele Massimo
    Gelsomino, Sandro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [26] Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter
    Malviya, Amit
    Kapoor, Manish
    Sivam, Rondeep Kumar Nath
    Khan, Shakeel Ahamad
    Pandey, Ruchi
    Kumar, Utpal
    Ete, Tony
    Mishra, Animesh
    INDIAN HEART JOURNAL, 2020, 72 (04) : 283 - 288
  • [27] Vernakalant: Conversion of atrial fibrillation in patients with ischemic heart disease
    Torp-Pedersen, Christian
    Camm, A. John
    Butterfield, Noam N.
    Dickinson, Garth
    Beatch, Gregory N.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 166 (01) : 147 - 151
  • [28] Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
    Slot, Karsten M. H. Bruins
    Berge, Eivind
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
  • [29] Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
    Slot, Karsten M. H. Bruins
    Berge, Eivind
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (03):
  • [30] Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis
    Van Der Meersch, Hans
    De Bacquer, Dirk
    De Vriese, An S.
    AMERICAN HEART JOURNAL, 2017, 184 : 37 - 46
12345